Cancer Flashcards

1
Q

List of proto-oncogenes

A
  1. HER2/Neu 2. Ret 3. Ras 4. Myc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List of tumor suppressor genes

A
  1. BRCA 2. APC 3. Rb 4. p53 5. MEN1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Systemic therapies for Colorectal Cancer (non-metastatic)

A
  1. FOLFOX (Folfiniic Acid, 5-FU, Oxaliplatin) 2. CAPEOX
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Systemic therapies for metastatic colorectal cancer

A
  1. FOLFIRI 2. FOLFOXIRI +/- Avastin (TK inhibitor VEGF) +/- Cetuximab (TK inhibitor EGFR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Systemic therapies for non metastatic biliary tract cancers

A

1.Gemcitabine 2. Capecitabine (Bilcap)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Systemic therapies for metastatic biliary tract cancers

A
  1. Gemcitabine + Cisplatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Systemic therapies for Pancreas cancer

A
  1. Gemcitibine + Capecitabine 2. Gemcitabine + Albumin bound Paclitaxel (Abraxane) 3. FOLFIRINOX
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Systemic therapies for Gastric cancer

A
  1. Epirubicin (unwind the strand) + Cisplatin (hurt the strand w crosslinks)+ 5-FU (ECF) 2. 5FU + Oxaliplatin (hurt the strand w crosslinks) + Docetaxol (microtubules) (FLOT) 3. FOLFOX 4. Trastuzumab (metastatic )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Systemic therapies for HCC

A

Sorafenib (TK inhibitor VEGFR, PDGFR) (metastatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Systemic therapies for Breast Cancer

A
  1. Trastuzumab (TK inhibitor Her2/Neu) 2. Pertuzumab (TK inhibitor Her2) 3. Docetaxol/Paclitaxel (microtubules) + Carboplatin (hurt the strand w crosslinks) 4. Adriamycin (Doxorubicin) (unwind the strand) + Cyclophosphamide (hurt the strand w crosslinks)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Systemic therapies for melanoma

A
  1. Pembrolizumab (anti PD-1) 2. Nivolumab (anti PD-1) 3. Ipilimumab (anti CTLA-4) 4. Dabrafenib (BRAF inhibitor) + Trametinib (MEK inhibitor) 5. IL2 6. Interferon Alpha
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Systemic therapies for GIST

A
  1. Imatinib (TK inhibitor C-kit) 2. Sunitinib (TK inhibitor BCR-ABL, SRC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

systemic therapies for metastatic neuroendocrine tumor

A
  1. Everolimus (mTOR inhibitor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

FAP (Gene + Cancers)

A

APC 1. GI polyposis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HNPCC (Lynch)

A

MMR (mismatch repair) (MLH1, MSH2, MSH6, PMS2) 1. Colon 2. Endometrial 3. Stomach 4. Ovarian 5. Hepatobiliary 6. CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Juvenile polyposis

A

SMAD4 1. < 100 colon polyps

17
Q

Peutz-Jeghers

A

STK11 1. GI polyposis 2. Pancreas 3. Breast 4. Gastric 5. Ovarian 6. Testicular

18
Q

Li-Fraumeni

A

p53 1. Breast 2. Sarcoma 3. Brain 4. Leukemia 5. Medulloblastoma 6. Adrenocortical

19
Q

Cowden

A

PTEN 1. Breast 2. Endometrial 3. Thyroid

20
Q

Hereditary Breast/Ovarian

A

BRCA 1/2 1. Breast 2. Ovarian 3. Endometrial 4. Fallopian 5. Pancreas 6. Colorectal

21
Q

MAP (MUTY-H associated polyposis)

A

MUTY-H 1. Colon polyposis

22
Q

Hereditary diffuse Gastric cancer

A

CDH1 1. Lobular breast 2. Gastric

23
Q

Carney Stratakis

A

SDHD 1. GIST 2. Pheo 3. Pulmonary chondroma

24
Q

Von Hippel-Lindau

A

VHL 1. Retinal/cerebellar hemangioblastoma 2. RCC 3. Pheo 4. PanNET

25
Q

MEN1

A

MEN1 1. Parathyroid 2. Pancreatic islet 3. Pituitary

26
Q

MEN2A/B

A

RET A. MTC, pheo, parathyroid B. MTC, pheo, neuroma

27
Q

Work up for CUP (cancer of unknown primary) exclusive of head/neck mass of unknown primary

A
  1. History and physical exam
  2. CT C/A/P
  3. If liver lesions
    1. Endoscopy
  4. If mediastinal lesions
    1. AFP/BHCG if male w concern for testicular
    2. CA 125 for female w concern for ovarian
  5. If male > 50, PSA with concern for prostate
28
Q

Treatment for CUP

A

if inguinal, then node dissection and RT/chemo

if axillary, male should to LN dissection and RT/chemo, if female, gets more complex.

29
Q

chylous ascites lab results

A

high in TG, high in leukocytes with lymphocyte predominance.